In Vivo Adaptation and Persistence of Neisseria meningitidis within the Nasopharyngeal Mucosa

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Johswich, Kay O ^a   McCaw, Shannon E ^a   Islam, Epshita ^a   Sintsova, Anna ^a   Gu, Angel ^b   Shively, John E ^b   Gray Owen, Scott D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CHEMOKINE; COMPLEMENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MENINGOCOCCUS VACCINE; MYELOPEROXIDASE; OPA PROTEIN; PILIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIABILITY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MENINGOCOCCOSIS; MOUSE; NASOPHARYNX; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; PERSISTENT INFECTION; POLYMORPHONUCLEAR CELL; SERUM BACTERICIDAL ANTIBODY ASSAY; VACCINATION; WESTERN BLOTTING;

EID: 84884743799     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003509     Document Type: Article

References (52)

1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. N Engl J Med 344: 1378-1388.
2. Cartwright KA, Stuart JM, Jones DM, Noah ND, (1987) The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99: 591-601.
3. Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, et al. (2003) A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Lett 222: 99-106.
4. Johansson L, Rytkonen A, Bergman P, Albiger B, Kallstrom H, et al. (2003) CD46 in meningococcal disease. Science 301: 373-375.
5. Mackinnon FG, Gorringe AR, Funnell SG, Robinson A, (1992) Intranasal infection of infant mice with Neisseria meningitidis. Microb Pathog 12: 415-420.
6. Salit IE, Van Melle E, Tomalty L, (1984) Experimental meningococcal infection in neonatal animals: models for mucosal invasiveness. Can J Microbiol 30: 1022-1029.
7. Yi K, Stephens DS, Stojiljkovic I, (2003) Development and evaluation of an improved mouse model of meningococcal colonization. Infect Immun 71: 1849-1855.
8. Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, et al. (2007) Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun 75: 5609-5614.
9. Gray-Owen SD, Dehio C, Haude A, Grunert F, Meyer TF, (1997) CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J 16: 3435-3445.
10. Virji M, Makepeace K, Ferguson DJ, Watt SM, (1996) Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol Microbiol 22: 941-950.
11. Chen T, Grunert F, Medina-Marino A, Gotschlich EC, (1997) Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins. J Exp Med 185: 1557-1564.
12. Gray-Owen SD, Lorenzen DR, Haude A, Meyer TF, Dehio C, (1997) Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Mol Microbiol 26: 971-980.
13. Muenzner P, Dehio C, Fujiwara T, Achtman M, Meyer TF, et al. (2000) Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells. Infect Immun 68: 3601-3607.
14. Virji M, Evans D, Hadfield A, Grunert F, Teixeira AM, et al. (1999) Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules. Mol Microbiol 34: 538-551.
15. Wang J, Gray-Owen SD, Knorre A, Meyer TF, Dehio C, (1998) Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers. Mol Microbiol 30: 657-671.
16. Boulton IC, Gray-Owen SD, (2002) Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 3: 229-236.
17. McCaw SE, Schneider J, Liao EH, Zimmermann W, Gray-Owen SD, (2003) Immunoreceptor tyrosine-based activation motif phosphorylation during engulfment of Neisseria gonorrhoeae by the neutrophil-restricted CEACAM3 (CD66d) receptor. Mol Microbiol 49: 623-637.
18. Schmitter T, Agerer F, Peterson L, Munzner P, Hauck CR, (2004) Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med 199: 35-46.
19. McCaw SE, Liao EH, Gray-Owen SD, (2004) Engulfment of Neisseria gonorrhoeae: revealing distinct processes of bacterial entry by individual carcinoembryonic antigen-related cellular adhesion molecule family receptors. Infect Immun 72: 2742-2752.
20. Gu A, Zhang Z, Zhang N, Tsark W, Shively JE, (2010) Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils. PLoS One 5: e10067.
21. Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, et al. (1996) CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem 44: 35-41.
22. Makino S, van Putten JP, Meyer TF, (1991) Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells. EMBO J 10: 1307-1315.
23. de Vries FP, van Der Ende A, van Putten JP, Dankert J, (1996) Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect Immun 64: 2998-3006.
24. Hammerschmidt S, Muller A, Sillmann H, Muhlenhoff M, Borrow R, et al. (1996) Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20: 1211-1220.
25. Murphy GL, Connell TD, Barritt DS, Koomey M, Cannon JG, (1989) Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell 56: 539-547.
26. Taha MK, Deghmane AE, Antignac A, Zarantonelli ML, Larribe M, et al. (2002) The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol 10: 376-382.
27. Lindberg K, Rynnel-Dagoo B, Sundqvist KG, (1994) Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media. Clin Exp Immunol 97: 396-402.
28. Swanson J, (1978) Studies on gonococcus infection. XIV. Cell wall protein differences among color/opacity colony variants of Neisseria gonorrhoeae. Infect Immun 21: 292-302.
29. Claus H, Maiden MC, Maag R, Frosch M, Vogel U, (2002) Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148: 1813-1819.
30. Virji M, Makepeace K, Ferguson DJ, Achtman M, Moxon ER, (1993) Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol 10: 499-510.
31. Stephens DS, Spellman PA, Swartley JS, (1993) Effect of the (alpha 2→8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J Infect Dis 167: 475-479.
32. Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, et al. (2007) Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. Journal of Infectious Diseases 195: 1071-1077.
33. Johswich KO, Zhou J, Law DK, St Michael F, McCaw SE, et al. (2012) Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis. Infect Immun 80: 2346-2353.
34. Estabrook MM, Griffiss JM, Jarvis GA, (1997) Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect Immun 65: 4436-4444.
35. Estabrook MM, Zhou D, Apicella MA, (1998) Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils. Infect Immun 66: 1028-1036.
36. Borrow R, Balmer P, Miller E, (2005) Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23: 2222-2227.
37. Trotter CL, Maiden MC, (2009) Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 8: 851-861.
38. McGee ZA, Stephens DS, Hoffman LH, Schlech WF 3rd, Horn RG, (1983) Mechanisms of mucosal invasion by pathogenic Neisseria. Rev Infect Dis 5 Suppl 4: S708-714.
39. Yazdankhah SP, Caugant DA, (2004) Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 53: 821-832.
40. Higashi DL, Lee SW, Snyder A, Weyand NJ, Bakke A, et al. (2007) Dynamics of Neisseria gonorrhoeae attachment: microcolony development, cortical plaque formation, and cytoprotection. Infect Immun 75: 4743-4753.
41. Mueller JE, Gessner BD, (2010) A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. Int J Infect Dis 14: e553-559.
42. Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, et al. (2009) Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun 77: 3588-3595.
43. Booy R, Iskander M, Viner R, (2007) Prevention of meningococcal disease. N Engl J Med 356: 524-525 author reply 525-526.
44. Schneider MC, Exley RM, Ram S, Sim RB, Tang CM, (2007) Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 15: 233-240.
45. Granoff DM, Welsch JA, Ram S, (2009) Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun 77: 764-769.
46. Jarva H, Ram S, Vogel U, Blom AM, Meri S, (2005) Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol 174: 6299-6307.
47. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510.
48. Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, et al. (2006) Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176: 7566-7575.
49. Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, et al. (2012) Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun 80: 643-650.
50. Wing JB, Smart L, Borrow R, Findlow J, Findlow H, et al. (2011) Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination. Clin Infect Dis 52: 1317-1323.
51. Achtman M, Neibert M, Crowe BA, Strittmatter W, Kusecek B, et al. (1988) Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med 168: 507-525.
52. Chan CH, Stanners CP, (2004) Novel mouse model for carcinoembryonic antigen-based therapy. Mol Ther 9: 775-785.